Amos Cohen

Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

Naftaly Meydan, T Grunberger, Harjit Dadi et al. · Nature · 1996 · 910 citations

Hematological Malignancy, Malignant Blood Disorder, Immunology +4

Defective T cell receptor signaling and CD8+ thymic selection in humans lacking Zap-70 kinase

Enrico Arpaia, Michal Shahar, Harjit Dadi et al. · Cell · 1994 · 549 citations

Cd8+ Thymic Selection, Signal Transduction, Autoimmune Disease +12

Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.

Amos Cohen, R Hirschhorn, Sheldon D. Horowitz et al. · Proceedings of the National Academy of Sciences · 1978 · 400 citations · Full text

Deoxyadenosine Triphosphate, Aldo-keto Reductase, Aldehyde Dehydrogenase +13

Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation

HM Lederman, Amos Cohen, M. H. Freedman et al. · Blood · 1984 · 279 citations · Full text

Crizotinib in Advanced, Chemoresistant Anaplastic Lymphoma Kinase–Positive Lymphoma Patients

Carlo Gambacorti‐Passerini, Francesca Farina, Alessandra Stasia et al. · JNCI Journal of the National Cancer Institute · 2014 · 275 citations

Hematological Malignancy, Lymphoid Neoplasia, Alk+ Lymphoma Patients +9